Company Overview and News


Add ABLX
to your dashboard

Headline News

ABYLY / Ablynx NV - Stock Institutional Ownership and Shareholders - Fintel.io

2017-11-30 fintel.io
Ablynx NV (OTC:ABYLY) has 1 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 5,883,306 shares. Largest shareholders include Van Herk Investments B.v..

Ablynx: To ASH And Beyond

2017-11-28 seekingalpha
Lead candidate caplacizumab has peak sales potential of €800 million and results from phase 3 HERCULES study were selected as one of only six oral abstracts to be presented at ASH. (69-0)

U.S. IPO Weekly Recap: Chinese Lenders Slide In Quiet Thanksgiving Week

2017-11-25 seekingalpha
With investors opting for turkey over deals, Thanksgiving week was slow for the IPO market. Senior housing SPAC Big Rock Partners Acquisition (BRPAU) was the only company to come public, raising $60 million. This week, quiet periods expired for antibody biotech Ablynx (NASDAQ:ABLX), BP Midstream LP (Pending:BPMP), National Vision Holdings (NASDAQ:EYE), ForeScout Technologies (NASDAQ:FSCT), Merchants Bancorp (NASDAQ:MBIN) and Nexa Resources (Pending:NEXA). (32-3)

U.S. IPO Week Ahead: Turkey, Gravy And IPO Filings In A Week With No Pricings

2017-11-19 seekingalpha
After a flurry of deals over the past two months, the pre-Thanksgiving rush has come to a close. No IPOs are pricing in the week ahead. However, this is the last week for most companies to submit initial filings with enough time to price IPOs before year-end. Quiet periods will expire for six recent IPOs this week, with street research expected for antibody biotech Ablynx (NASDAQ:ABLX), BP Midstream LP (Pending:BPMP), National Vision Holdings (NASDAQ:EYE), ForeScout Technologies (NASDAQ:FSCT), Merchants Bancorp (NASDAQ:MBIN) and Nexa Resources (Pending:NEXA). (46-1)

IPO News This Week: 9 Firms Seeking Total of $2 Billion in Capital

2017-10-29 247wallst
There were eight initial public offerings (IPOs) on the calendar last week and six succeeded in gaining access to the public markets. The total amount raised over $2 billion and the average first-day pop was around 13.7%. (95-0)

U.S. IPO Weekly Recap: Investors Eye National Vision In 6-IPO Week

2017-10-28 seekingalpha
In another active week for the IPO market, six companies in six different sectors raised over $2 billion. Boasting strong comp growth, National Vision (NASDAQ:EYE) was the top performer with a 28% gain as investors put a premium on the Amazon (NASDAQ:AMZN)-proof retailer. The week's other two growth stories, cybersecurity unicorn ForeScout Technologies (FSCT) and antibody biotech Ablynx (Pending:ABLX), were also well received. (115-0)

BRIEF-Ablynx prices $200 mln IPO in the United States

2017-10-25 reuters
* Ablynx NV - ‍prices us IPO totaling $200 million proceeds from sale of 11.43 million shares in form of American depositary shares at price of $17.50/ADS​ Source text for Eikon: Further company coverage:

IPO News This Week: BP Midstream Leads 8 Scheduled IPOs

2017-10-22 247wallst
There were six initial public offerings (IPOs) on the calendar last week and five succeeded in gaining access to the public markets. The total amount raised was $2.15 billion and the average first-day pop was around 14%. (104-0)

U.S. IPO Week Ahead: Cybersecurity Unicorn ForeScout Technologies Headlines 6-IPO, 6-Sector Week

2017-10-21 seekingalpha
The steady flow of IPOs in the 4Q is set to continue with six companies in six different sectors scheduled to raise a combined $2.1 billion in the week ahead. The diverse collection includes unicorn ForeScout Technologies (Private:SCOUT), an enterprise security software provider that hopes to follow the success of the most recent unicorn to IPO, MongoDB (Pending:MDB), which priced last week and popped 34% on its first day. (49-0)

Nanomedicine Market is anticipated to reach USD 350.8 billion by 2025

2017-05-30 prnewswire
·         The global nanomedicine market is anticipated to reach USD 350.8 billion by 2025, according to a new report by Grand View Research, Inc.

Bone Metastasis Therapeutic Pipeline Review H1 2017 Research Report Now Available at RnRMarketResearch.com

2017-05-24 prnewswire
RnRMarketResearch.com adds "Bone Metastasis - Pipeline Review, H1 2017" therapeutic market research report of 100 pages with latest updates, data and information to its online business intelligence library. (0-1)

Vectura Group's (VEGPF) CEO James Ward-Lilley on Q4 2016 Results - Earnings Call Transcript

2017-03-22 seekingalpha
Good morning, ladies and gentlemen. It’s a pleasure to be with you here this morning and great to see you in full of Analysts and Investor interest in the ongoing Vectura. Welcome to those who listening on the telephone or on the webcast.

Interim Results

2016-11-23 londonstockexchange
Chippenham, UK - 23 November 2016: Vectura Group plc (LSE: VEC) ("the Group"), an industry-leading device and formulation business for inhaled airways products, today announces its unaudited interim results for the six months ended 30 September 2016. 

Ablynx NV 2016 Q2 - Results - Earnings Call Slides

2016-08-25 seekingalpha
The following slide deck was published by Ablynx NV in conjunction with their 2016 Q2 earnings call.